The move comes as the entry-level SUV market grows increasingly competitive, with players aggressively vying for market share
India's pharmaceutical market rose 7.3% year-on-year in September to ₹20,886 crore, driven by robust growth in antidiabetic, cardiac, and respiratory therapies
Once niche and costly, genomic testing is becoming affordable across India as prices fall 30-40 per cent, with hospitals and diagnostic chains expanding into Tier-2 and Tier-3 cities
Company executives added that the Adventure X trims are expected to lift sales volumes, though average selling prices may soften compared with last year, when demand was led by high-end variants
Tata Motors announced major leadership changes as it prepares to demerge its commercial vehicle business into TML Commercial Vehicles Ltd, effective October 1, 2025
Crisil projects India pharma growth at 7-9% in FY26 as exports to regulated markets slow after a US high base while domestic sales benefit from tax cuts and launches
Vector Consulting Group study finds pharma firms spend up to ₹75 cr annually on IT systems, but 70% of digital projects fail due to adoption gaps and poor execution
Apollo Hospitals to expand genomics institutes to Tier-2 cities including Guwahati, Bhubaneswar and Indore, aiming to cut test costs and boost access beyond metro regions
With new GST rates kicking in, auto dealers face uncertainty on recovering compensation cess from unsold stock, even as OEMs cut prices to spur festive demand
Hisar-based Zelio E-Mobility to raise Rs 78 crore through an SME IPO to fund new plants, strengthen R&D, reduce debt and enhance capacity to meet growing demand for EVs
India's millionaire households have nearly doubled to 8.7 lakh in four years, creating a runway for luxury car demand as wealth fuels aspirations and premium consumption
Lupin has received USFDA approval for generic Lenalidomide capsules in six strengths, adding to competition in the US oncology market for Bristol-Myers Squibb's Revlimid
Spinny has reduced used car prices ahead of GST reforms from September 22, offering buyers up to Rs 2 lakh savings and sellers up to Rs 20,000 higher resale benefit
The simmering conflict came to a head last month when Niva Bupa suspended cashless services at Max Hospitals on August 16, citing unresolved reimbursement issues
Novartis lost its Vymada patent in India, enabling generic drugmakers to launch versions that could slash prices by up to 70 per cent and improve access for cardiac patients
The fifth edition of DSS was conducted in partnership with Singapore-based consultancy PremonAsia
Apollo Hospitals to acquire IFC's 30.58% stake in AHLL for Rs 1,254 crore, taking ownership to 99.42%, and invest Rs 573 crore in a next-gen proton therapy centre in Gurugram
In a strongly worded communication sent to the insurer, AHPI flagged long-standing grievances, including the refusal to revise hospital tariffs in line with rising healthcare costs
The GST Council recently cut tax rates on sub-350cc two-wheelers and three-wheelers from 28 per cent to 18 per cent, effective September 22, 2025
JBM Ecolife Mobility secured $100 million from IFC to deploy 1,455 electric buses in Maharashtra, Assam, and Gujarat, marking IFC's first capital investment in Asia's e-bus sector